Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,679 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical course of pathologically confirmed corticobasal degeneration and corticobasal syndrome.
Aiba I, Hayashi Y, Shimohata T, Yoshida M, Saito Y, Wakabayashi K, Komori T, Hasegawa M, Ikeuchi T, Tokumaru AM, Sakurai K, Murayama S, Hasegawa K, Uchihara T, Toyoshima Y, Saito Y, Yabe I, Tanikawa S, Sugaya K, Hayashi K, Sano T, Takao M, Sakai M, Fujimura H, Takigawa H, Adachi T, Hanajima R, Yokota O, Miki T, Iwasaki Y, Kobayashi M, Arai N, Ohkubo T, Yokota T, Mori K, Ito M, Ishida C, Tanaka M, Idezuka J, Kanazawa M, Aoki K, Aoki M, Hasegawa T, Watanabe H, Hashizume A, Niwa H, Yasui K, Ito K, Washimi Y, Mukai E, Kubota A, Toda T, Nakashima K; J-VAC study group. Aiba I, et al. Among authors: aoki k, aoki m. Brain Commun. 2023 Nov 3;5(6):fcad296. doi: 10.1093/braincomms/fcad296. eCollection 2023. Brain Commun. 2023. PMID: 38090279 Free PMC article.
Conventional magnetic resonance imaging key features for distinguishing pathologically confirmed corticobasal degeneration from its mimics: a retrospective analysis of the J-VAC study.
Sakurai K, Tokumaru AM, Yoshida M, Saito Y, Wakabayashi K, Komori T, Hasegawa M, Ikeuchi T, Hayashi Y, Shimohata T, Murayama S, Iwasaki Y, Uchihara T, Sakai M, Yabe I, Tanikawa S, Takigawa H, Adachi T, Hanajima R, Fujimura H, Hayashi K, Sugaya K, Hasegawa K, Sano T, Takao M, Yokota O, Miki T, Kobayashi M, Arai N, Ohkubo T, Yokota T, Mori K, Ito M, Ishida C, Idezuka J, Toyoshima Y, Kanazawa M, Aoki M, Hasegawa T, Watanabe H, Hashizume A, Niwa H, Yasui K, Ito K, Washimi Y, Kubota A, Toda T, Nakashima K, Aiba I; J-VAC study group. Sakurai K, et al. Among authors: aoki m. Neuroradiology. 2024 Nov;66(11):1917-1929. doi: 10.1007/s00234-024-03432-w. Epub 2024 Jul 22. Neuroradiology. 2024. PMID: 39039147 Free PMC article.
[Aceneuraminic acid for distal myopathy].
Aoki M. Aoki M. Nihon Yakurigaku Zasshi. 2025;160(1):48-52. doi: 10.1254/fpj.24090. Nihon Yakurigaku Zasshi. 2025. PMID: 39756906 Review. Japanese.
Oral edaravone demonstrated a favorable safety profile in patients with amyotrophic lateral sclerosis after 48 weeks of treatment.
Genge A, Pattee GL, Sobue G, Aoki M, Yoshino H, Couratier P, Lunetta C, Petri S, Selness D, Bidani S, Hirai M, Sakata T, Salah A, Apple S, Wamil A, Kalin A, Jackson CE. Genge A, et al. Among authors: aoki m. Muscle Nerve. 2023 Feb;67(2):124-129. doi: 10.1002/mus.27768. Epub 2022 Dec 28. Muscle Nerve. 2023. PMID: 36504406 Free PMC article. Clinical Trial.
Cybernic treatment with wearable cyborg Hybrid Assistive Limb (HAL) improves ambulatory function in patients with slowly progressive rare neuromuscular diseases: a multicentre, randomised, controlled crossover trial for efficacy and safety (NCY-3001).
Nakajima T, Sankai Y, Takata S, Kobayashi Y, Ando Y, Nakagawa M, Saito T, Saito K, Ishida C, Tamaoka A, Saotome T, Ikai T, Endo H, Ishii K, Morita M, Maeno T, Komai K, Ikeda T, Ishikawa Y, Maeshima S, Aoki M, Ito M, Mima T, Miura T, Matsuda J, Kawaguchi Y, Hayashi T, Shingu M, Kawamoto H. Nakajima T, et al. Among authors: aoki m. Orphanet J Rare Dis. 2021 Jul 7;16(1):304. doi: 10.1186/s13023-021-01928-9. Orphanet J Rare Dis. 2021. PMID: 34233722 Free PMC article. Clinical Trial.
A Retrospective Cohort Study of a Newly Proposed Criteria for Sporadic Creutzfeldt-Jakob Disease.
Nonaka T, Ae R, Kosami K, Tange H, Kaneko M, Nakagaki T, Hamaguchi T, Sanjo N, Nakamura Y, Kitamoto T, Kuroiwa Y, Kasuga K, Doyu M, Tanaka F, Abe K, Murayama S, Yabe I, Mochizuki H, Matsushita T, Murai H, Aoki M, Fujita K, Harada M, Takao M, Tsukamoto T, Iwasaki Y, Yamada M, Mizusawa H, Satoh K, Nishida N. Nonaka T, et al. Among authors: aoki m. Diagnostics (Basel). 2024 Oct 30;14(21):2424. doi: 10.3390/diagnostics14212424. Diagnostics (Basel). 2024. PMID: 39518392 Free PMC article.
Neurofibromatosis type 1 (NF1) tumor suppressor, neurofibromin, regulates the neuronal differentiation of PC12 cells via its associating protein, CRMP-2.
Patrakitkomjorn S, Kobayashi D, Morikawa T, Wilson MM, Tsubota N, Irie A, Ozawa T, Aoki M, Arimura N, Kaibuchi K, Saya H, Araki N. Patrakitkomjorn S, et al. Among authors: aoki m. J Biol Chem. 2008 Apr 4;283(14):9399-413. doi: 10.1074/jbc.M708206200. Epub 2008 Jan 23. J Biol Chem. 2008. PMID: 18218617 Free article.
3,679 results